髓细胞白血病-话题@MedSci

#髓细胞白血病#

34篇内容 | 471人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1822183, encodeId=f9c318221839b, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=haematol： DDX41突变在意义不明的特发性血细胞减少症、骨髓增生异常综合征或急性髓细胞白血病患者中的独特种族特征 , objectType=article, longId=299300, objectId=6c4d299300d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c4d299300d6, replyNumber=0, likeNumber=40, createdTime=2022-04-19, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c4d299300d6, moduleTitle=haematol： DDX41突变在意义不明的特发性血细胞减少症、骨髓增生异常综合征或急性髓细胞白血病患者中的独特种族特征 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c4d299300d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822182, encodeId=f1651822182bf, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=BJH：在标准急性髓细胞白血病化疗方案中添加奥马西他辛可降低细胞 FLIP 水平，并显着增加外泌汗腺炎的发病率, objectType=article, longId=294272, objectId=891c2942e26d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891c2942e26d, replyNumber=0, likeNumber=39, createdTime=2022-03-31, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891c2942e26d, moduleTitle=BJH：在标准急性髓细胞白血病化疗方案中添加奥马西他辛可降低细胞 FLIP 水平，并显着增加外泌汗腺炎的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891c2942e26d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822187, encodeId=53ea182218e09, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究, objectType=article, longId=730781, objectId=f847e307815e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f847e307815e, replyNumber=0, likeNumber=25, createdTime=2023-04-04, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f847e307815e, moduleTitle=Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f847e307815e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822186, encodeId=cbda182218667, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Hematology ：血小板与白细胞比率是急性髓细胞白血病的独立预后预测因子, objectType=article, longId=724597, objectId=53afe245976f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53afe245976f, replyNumber=0, likeNumber=45, createdTime=2022-08-07, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53afe245976f, moduleTitle=Hematology ：血小板与白细胞比率是急性髓细胞白血病的独立预后预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53afe245976f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822181, encodeId=f5bf1822181bd, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Int J Cancer：患有急性髓细胞白血病的儿童、青少年和青壮年的生存差异, objectType=article, longId=292223, objectId=75db29222329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75db29222329, replyNumber=0, likeNumber=32, createdTime=2022-09-07, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75db29222329, moduleTitle=Int J Cancer：患有急性髓细胞白血病的儿童、青少年和青壮年的生存差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75db29222329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822184, encodeId=c78d182218427, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Haematologica：APR-246 通过铁死亡诱导急性髓细胞白血病早期细胞死亡, objectType=article, longId=299385, objectId=bf15299385c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf15299385c0, replyNumber=0, likeNumber=37, createdTime=2022-05-19, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf15299385c0, moduleTitle=Haematologica：APR-246 通过铁死亡诱导急性髓细胞白血病早期细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf15299385c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822185, encodeId=00781822185ea, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响, objectType=article, longId=300555, objectId=c2d0300555d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2d0300555d0, replyNumber=0, likeNumber=27, createdTime=2022-06-03, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2d0300555d0, moduleTitle=Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2d0300555d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822179, encodeId=5caa18221e9a0, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=ASH 2020：研究性新药Alvocidib治疗复发难治急性髓细胞白血病（AML）, objectType=article, longId=203075, objectId=8c062030e5cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c062030e5cf, replyNumber=0, likeNumber=32, createdTime=2021-05-23, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c062030e5cf, moduleTitle=ASH 2020：研究性新药Alvocidib治疗复发难治急性髓细胞白血病（AML）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c062030e5cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822177, encodeId=795318221e713, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=第23届ASGCT：细胞疗法NTLA-5001治疗急性髓细胞白血病！, objectType=article, longId=194136, objectId=2fd31941363f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd31941363f, replyNumber=0, likeNumber=39, createdTime=2020-09-26, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd31941363f, moduleTitle=第23届ASGCT：细胞疗法NTLA-5001治疗急性髓细胞白血病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd31941363f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822178, encodeId=33dc18221e85f, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Brit J Heamatol：低密度脂蛋白受体是急性髓细胞白血病患者的不良预后因素, objectType=article, longId=196781, objectId=b8d0196e81f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8d0196e81f1, replyNumber=0, likeNumber=35, createdTime=2020-10-19, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8d0196e81f1, moduleTitle=Brit J Heamatol：低密度脂蛋白受体是急性髓细胞白血病患者的不良预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8d0196e81f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822180, encodeId=a3b51822180f7, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=JAMA Oncology：慢性髓细胞白血病患者停用酪氨酸激酶抑制剂后的预后评估, objectType=article, longId=203471, objectId=188b2034e1e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=188b2034e1e6, replyNumber=0, likeNumber=48, createdTime=2021-08-16, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=188b2034e1e6, moduleTitle=JAMA Oncology：慢性髓细胞白血病患者停用酪氨酸激酶抑制剂后的预后评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=188b2034e1e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822175, encodeId=c6a318221e56f, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果, objectType=article, longId=185151, objectId=1a4f18515140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a4f18515140, replyNumber=0, likeNumber=40, createdTime=2020-04-20, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a4f18515140, moduleTitle=Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a4f18515140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822173, encodeId=bdc018221e391, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, objectType=article, longId=176182, objectId=3d741e61824e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d741e61824e, replyNumber=0, likeNumber=34, createdTime=2020-03-16, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d741e61824e, moduleTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d741e61824e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822174, encodeId=eeaf18221e47d, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, objectType=article, longId=177301, objectId=41851e73015c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41851e73015c, replyNumber=0, likeNumber=34, createdTime=2019-10-28, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41851e73015c, moduleTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41851e73015c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822176, encodeId=936b18221e60f, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Cellectis的同种异体CAR-T细胞疗法（UCART）开始用于治疗复发/难治性急性髓细胞白血病患者, objectType=article, longId=186372, objectId=76531863e2f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76531863e2f1, replyNumber=0, likeNumber=28, createdTime=2020-05-14, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76531863e2f1, moduleTitle=Cellectis的同种异体CAR-T细胞疗法（UCART）开始用于治疗复发/难治性急性髓细胞白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76531863e2f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822171, encodeId=679b18221e122, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, objectType=article, longId=167756, objectId=3be616e75661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be616e75661, replyNumber=0, likeNumber=50, createdTime=2020-04-28, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be616e75661, moduleTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be616e75661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822172, encodeId=f42118221e208, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, objectType=article, longId=176178, objectId=4e8f1e617823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8f1e617823, replyNumber=0, likeNumber=39, createdTime=2019-08-14, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8f1e617823, moduleTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e8f1e617823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822170, encodeId=213c18221e0cf, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, objectType=article, longId=158465, objectId=a47115846533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a47115846533, replyNumber=0, likeNumber=33, createdTime=2019-07-21, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a47115846533, moduleTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a47115846533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822169, encodeId=44bf182216969, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=J INTERN MED：继发性急性髓细胞白血病首次缓解期间的脐带血移植与良好预后相关, objectType=article, longId=156149, objectId=d4ce1561490f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ce1561490f, replyNumber=0, likeNumber=28, createdTime=2019-05-22, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ce1561490f, moduleTitle=J INTERN MED：继发性急性髓细胞白血病首次缓解期间的脐带血移植与良好预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4ce1561490f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822164, encodeId=4cce1822164b6, content=<a href='/topic/show?id=b8611021308a' target=_blank style='color:#2F92EE;'>#髓细胞白血病#</a>, objectTitle=Sci Transl Med：美研发出急性髓细胞白血病新药, objectType=article, longId=135181, objectId=ca9c1351814f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9c1351814f, replyNumber=0, likeNumber=37, createdTime=2019-01-04, rootId=0, userName=shenxlcyp, userId=a9de34, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9c1351814f, moduleTitle=Sci Transl Med：美研发出急性髓细胞白血病新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9c1351814f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

髓细胞白血病

2020-05-29

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

haematol： DDX41突变在意义不明的特发性血细胞减少症、骨髓增生异常综合征或急性髓细胞白血病患者中的独特种族特征

2022-04-19

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

BJH：在标准急性髓细胞白血病化疗方案中添加奥马西他辛可降低细胞 FLIP 水平，并显着增加外泌汗腺炎的发病率

2022-03-31

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究

2023-04-04

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Hematology ：血小板与白细胞比率是急性髓细胞白血病的独立预后预测因子

2022-08-07

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Int J Cancer：患有急性髓细胞白血病的儿童、青少年和青壮年的生存差异

2022-09-07

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Haematologica：APR-246 通过铁死亡诱导急性髓细胞白血病早期细胞死亡

2022-05-19

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响

2022-06-03

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

ASH 2020：研究性新药Alvocidib治疗复发难治急性髓细胞白血病（AML）

2021-05-23

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

第23届ASGCT：细胞疗法NTLA-5001治疗急性髓细胞白血病！

2020-09-26

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Brit J Heamatol：低密度脂蛋白受体是急性髓细胞白血病患者的不良预后因素

2020-10-19

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

JAMA Oncology：慢性髓细胞白血病患者停用酪氨酸激酶抑制剂后的预后评估

2021-08-16

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果

2020-04-20

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定

2020-03-16

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡

2019-10-28

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Cellectis的同种异体CAR-T细胞疗法（UCART）开始用于治疗复发/难治性急性髓细胞白血病患者

2020-05-14

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定

2020-04-28

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病

2019-08-14

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法

2019-07-21

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

J INTERN MED：继发性急性髓细胞白血病首次缓解期间的脐带血移植与良好预后相关

2019-05-22

shenxlcyp (审核中...)

前往app查看评论内容

#髓细胞白血病#

Sci Transl Med：美研发出急性髓细胞白血病新药

2019-01-04

科室
- - 订阅+
  - 更多科室
工具
服务